Article Link: FDA Approves Inqovi (decitabine and cedazuridine) for Myelodysplastic Syndromes (MDS) including Chronic Myelomonocytic Leukemia (CMML)&#...
FDA Approves Qwo (collagenase clostridium histolyticum-aaes) as the First Injectable Treatment for Cellulite
Article Link: FDA Approves Qwo (collagenase clostridium histolyticum-aaes) as the First Injectable Treatment for Cellulite DUBLIN, July 6...
FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation
Article Link: FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation Dublin, Ireland – 2 Ju...
FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available
Article Link: FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available July 2, 2020 — ViiV Healthc...
FDA Approves Dojolvi (triheptanoin) for the Treatment of Long-Chain Fatty Acid Oxidation Disorders
Article Link: FDA Approves Dojolvi (triheptanoin) for the Treatment of Long-Chain Fatty Acid Oxidation Disorders NOVATO, Calif., June 30,...
FDA Approves Bavencio as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Article Link: FDA Approves Bavencio as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma &#...
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer
Article Link: FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer South San Francisco, ...
FDA Approves Merck’s Keytruda (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer
Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorec...
FDA Approves Mycapssa (octreotide) Oral Somatostatin Analog for Acromegaly
Article Link: FDA Approves Mycapssa (octreotide) Oral Somatostatin Analog for Acromegaly NEEDHAM, Mass., June 26, 2020 (GLOBE NEWSWIRE) &...
FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome
Article Link: FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome EMERYVILLE, Calif., June...
